Background Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19
antiviral treatments, but their antiviral activities in patients have not been compared …

Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …

Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …

Aims Millions of people died during the COVID-19 pandemic, but the vast majority of infected
individuals survived. Now, some consequences of the disease, known as long COVID, are …

Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …

Background Uncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …

1990). Mais recentemente foi introduzido o conceito de sector, que visa a melhor compreensão
dos vários depocentros, independentemente dos seus limites geográficos coincidirem …

BACKGROUND Similarly to women, men suffer from engaging in fertility treatments, both
physically and psychologically. Although there is a vast body of evidence on the emotional …

Mesenchymal stem cells (MSCs) have been used for cell-based therapies in regenerative
medicine, with increasing importance in central and peripheral nervous system repair. …

Ribosomes and a subset of cellular mRNAs are trafficked into axons of developing neurons.
The axonal localization of translational machinery allows new proteins to be rapidly and …